ArticleJournal of advanced research2025

KBTBD8/RRP15 as a potential novel therapeutic target associates with lenvatinib-inhibited progression in hepatocellular carcinoma both in vitro and in vivo.

Saili Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.